Fernando Pagán

2.7k total citations
73 papers, 1.7k citations indexed

About

Fernando Pagán is a scholar working on Neurology, Cellular and Molecular Neuroscience and Hematology. According to data from OpenAlex, Fernando Pagán has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 9 papers in Hematology. Recurrent topics in Fernando Pagán's work include Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (34 papers) and Botulinum Toxin and Related Neurological Disorders (23 papers). Fernando Pagán is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (34 papers) and Botulinum Toxin and Related Neurological Disorders (23 papers). Fernando Pagán collaborates with scholars based in United States, Germany and Greece. Fernando Pagán's co-authors include Yasar Torres‐Yaghi, John A. Butman, Jaeil Ahn, Charbel Moussa, Michaeline Hebron, Mark Hallett, Barbara Wilmarth, Abigail Lawler, James M. Dambrosia and Edward B. Healton and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Neurology.

In The Last Decade

Fernando Pagán

69 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Pagán United States 21 1.1k 501 309 224 214 73 1.7k
Flavia Niccolini United Kingdom 25 1.1k 1.1× 706 1.4× 287 0.9× 522 2.3× 199 0.9× 46 1.9k
Lothar Burghaus Germany 20 707 0.7× 385 0.8× 200 0.6× 292 1.3× 170 0.8× 61 1.5k
Christopher Kenney United States 21 1.3k 1.2× 749 1.5× 186 0.6× 275 1.2× 178 0.8× 32 2.0k
Zinovia Kefalopoulou Greece 15 930 0.9× 439 0.9× 170 0.6× 225 1.0× 176 0.8× 29 1.4k
Icíar Avilés-Olmos United Kingdom 19 1.8k 1.6× 898 1.8× 463 1.5× 488 2.2× 346 1.6× 39 2.7k
Khashayar Dashtipour United States 24 918 0.8× 590 1.2× 255 0.8× 232 1.0× 75 0.4× 70 1.7k
Eduardo De Pablo‐Fernández United Kingdom 20 1.1k 1.0× 307 0.6× 222 0.7× 247 1.1× 179 0.8× 45 1.5k
Anne M. Landau Denmark 21 431 0.4× 494 1.0× 276 0.9× 288 1.3× 156 0.7× 81 1.2k
Chuantao Zuo China 30 1.3k 1.2× 483 1.0× 621 2.0× 277 1.2× 338 1.6× 164 2.6k
Wei Song China 25 1.2k 1.1× 388 0.8× 279 0.9× 645 2.9× 315 1.5× 106 2.1k

Countries citing papers authored by Fernando Pagán

Since Specialization
Citations

This map shows the geographic impact of Fernando Pagán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Pagán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Pagán more than expected).

Fields of papers citing papers by Fernando Pagán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Pagán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Pagán. The network helps show where Fernando Pagán may publish in the future.

Co-authorship network of co-authors of Fernando Pagán

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Pagán. A scholar is included among the top collaborators of Fernando Pagán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Pagán. Fernando Pagán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pagán, Fernando, Paul E. Schulz, Yasar Torres‐Yaghi, & Gregory M. Pontone. (2024). On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis. CNS Drugs. 38(5). 333–347. 4 indexed citations
3.
Isaacson, Stuart, Richard B. Dewey, Robert A. Hauser, et al.. (2024). Apomorphine titration with and without anti-emetic pretreatment in patients with Parkinson’s disease experiencing OFF episodes: A modified Delphi panel. Clinical Parkinsonism & Related Disorders. 11. 100264–100264. 1 indexed citations
4.
Pahwa, Rajesh, Fernando Pagán, Daniel Kremens, & Marie Saint‐Hilaire. (2023). Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods. Neurology and Therapy. 12(4). 1033–1049. 7 indexed citations
5.
Torres‐Yaghi, Yasar, Nobutaka Hattori, Olivier Rascol, et al.. (2023). Istradefylline effects on tremor dominance (TD) and postural instability and gait difficulty (PIGD). Clinical Parkinsonism & Related Disorders. 9. 100224–100224. 3 indexed citations
6.
Torres‐Yaghi, Yasar, et al.. (2022). Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic. Telemedicine Journal and e-Health. 28(11). 1651–1657. 1 indexed citations
7.
Pahwa, Rajesh, Stuart Isaacson, Gary W. Small, et al.. (2022). Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel. Neurology and Therapy. 11(4). 1571–1582. 4 indexed citations
8.
Torres‐Yaghi, Yasar, et al.. (2021). QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review. Dove Medical Press (Taylor and Francis Group). 10 indexed citations
9.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, Jaeil Ahn, & Charbel Moussa. (2021). Long-term Safety and Clinical Effects of Nilotinib in Parkinson’s Disease (4799). Neurology. 96(15_supplement). 1 indexed citations
10.
Fayed, Islam, Yasar Torres‐Yaghi, Fernando Pagán, et al.. (2021). Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson’s disease. Journal of Clinical Neuroscience. 85. 92–100. 6 indexed citations
11.
Fowler, Alan J., Michaeline Hebron, Yasar Torres‐Yaghi, et al.. (2020). A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration (5398). Neurology. 94(15_supplement). 1 indexed citations
12.
Jost, Wolfgang H., Andrzej Friedman, Olaf Michel, et al.. (2019). Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks. Parkinsonism & Related Disorders. 70. 23–30. 23 indexed citations
13.
Mitsikostas, Dimos D., et al.. (2018). Safety and Efficacy of Incobotulinum toxin A for the Treatment of Blepharospasm in Botulinum Toxin-Naive Subjects (P5.041). Neurology. 90(15_supplement). 1 indexed citations
14.
Zorowitz, Richard D., Theodore Wein, Kari Dunning, et al.. (2016). A Screening Tool to Identify Spasticity in Need of Treatment. American Journal of Physical Medicine & Rehabilitation. 96(5). 315–320. 9 indexed citations
15.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2016). Nilotinib Improves Motor Skills, Cognition and Autonomic Function in Open-Label Phase I Clinical Trial in Parkinsons Disease with Dementia and Lewy Body Dementia (I1.008). Neurology. 86(16_supplement). 1 indexed citations
16.
Pagán, Fernando, et al.. (2015). Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A. Patient Preference and Adherence. 9. 725–725. 7 indexed citations
17.
Shimoji, Mika, Fernando Pagán, Edward B. Healton, & Italo Mocchetti. (2009). CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson’s Disease. Neurotoxicity Research. 16(3). 318–328. 82 indexed citations
18.
Tagliati, Michele, et al.. (2009). Safety of MRI in patients with implanted deep brain stimulation devices. NeuroImage. 47. T53–T57. 83 indexed citations
19.
Lerner, Alicja, Anto Bagić, Takashi Hanakawa, et al.. (2008). Involvement of Insula and Cingulate Cortices in Control and Suppression of Natural Urges. Cerebral Cortex. 19(1). 218–223. 86 indexed citations
20.
Colton, Carol A., et al.. (1995). Protection from oxidation enhances the survival of cultured mesencephalic neurons. Experimental Neurology. 132(1). 54–61. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flavia Niccolini Breakdown of academic impact, for papers by Lothar Burghaus Breakdown of academic impact, for papers by Christopher Kenney Breakdown of academic impact, for papers by Zinovia Kefalopoulou Breakdown of academic impact, for papers by Icíar Avilés-Olmos Breakdown of academic impact, for papers by Khashayar Dashtipour Breakdown of academic impact, for papers by Eduardo De Pablo‐Fernández Breakdown of academic impact, for papers by Anne M. Landau Breakdown of academic impact, for papers by Chuantao Zuo Breakdown of academic impact, for papers by Wei Song
Rankless by CCL
2026